Remnant gastric cancer: a neglected group with high potential for immunotherapy.
Marcus Fernando Kodama Pertille RamosMarina Alessandra PereiraTiago Biachi de CastriaRenan Ribeiro E RibeiroLeonardo CardiliEvandro Sobroza de MelloBruno ZilbersteinUlysses Ribeiro JuniorIvan CecconeloPublished in: Journal of cancer research and clinical oncology (2020)
RGC had higher incidence of MSI than PGC, and CPS-positive RGC was associated with better survival. The immunological profile of RGC patients suggests that they would be good candidates for immunotherapy.